Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp (TCNNF) provides comprehensive medical and recreational cannabis products through its vertically integrated operations across multiple U.S. states. This news hub offers investors and stakeholders direct access to official corporate announcements, financial disclosures, and operational updates.
Discover timely information about earnings reports, regulatory compliance milestones, dispensary expansions, and product innovations. Our curated collection ensures transparent tracking of Trulieve's market leadership in cultivation practices and retail operations within strictly regulated environments.
Key updates include strategic acquisitions, new market entries, sustainability initiatives, and advancements in medical cannabis research. All content originates from verified company communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of TCNNF's operational developments and industry positioning. Check regularly for updates on one of the cannabis sector's most influential multi-state operators.
Trulieve Cannabis Corp. is hosting a Listening and Education Tour in Georgia to engage local leaders on the benefits of the cannabis industry. The inaugural event will occur on February 25, 2022, at the Carolyn Harris Performing Arts Center in Adel. Moderated by Champ Bailey, the tour aims to discuss medical, economic, agricultural, and expungement opportunities. Trulieve received a Class 1 production license from the Georgia Access to Medical Cannabis Commission in July 2021. Community participation is encouraged, and future dates will be announced.
Trulieve Cannabis Corp. has finalized the acquisition of a 64,000 sq. ft. cultivation facility in Phoenix, Arizona for $13.75 million. This facility enhances the company’s cultivation capacity and strengthens its market presence in the Southwest. It also serves Trulieve’s 17 dispensaries in Arizona, providing high-quality products to both medical and adult-use customers. CEO Kim Rivers emphasized the strategic importance of this acquisition for improving supply chain capacity and expanding service to a larger customer base.
Trulieve Cannabis Corp. has opened its 112th dispensary in Riverview, Florida, effective February 10, 2022. The new location aims to enhance patient accessibility to medical cannabis and will feature grand opening specials, including a 25% discount for registered patients. Customers also benefit from a 50% discount for first-time visitors at any Florida location. Trulieve emphasizes personalized patient care and offers a variety of THC and CBD products, ensuring comprehensive support throughout the cannabis journey.
Trulieve Cannabis Corp. has announced the launch of two proprietary brands, Sweet Talk™ and Momenta™, alongside new product releases in Florida. The Momenta line focuses on holistic wellness, while Sweet Talk offers tasty edibles, starting with strawberry gels. The company will also release the second batch of Live Diamonds by Muse and introduce the Cultivar Collection of premium whole flower. These offerings aim to enhance Trulieve’s position as a leading cannabis provider in Florida, catering to the growing patient community.
Trulieve Cannabis Corp. has successfully closed a second tranche of its private placement of 8% Senior Secured Notes, raising US$75.0 million. This follows an earlier tranche in October 2021, bringing total gross proceeds to US$425.0 million. The funds will be allocated for capital expenditures and general corporate purposes. CEO Kim Rivers highlighted the company's strong financial profile, enabling access to favorable growth capital. The Notes will be listed on the Canadian Securities Exchange post a statutory hold period.
Trulieve Cannabis Corp. has partnered with Miami Mango to launch the Mango Haze strain exclusively for South Florida medical patients. Set to debut in late February, this partnership aims to enhance Trulieve's product offerings, showcasing a commitment to quality and patient care. Trulieve continues to dominate Florida's medical cannabis market, providing a wide range of products, including flower, pre-rolls, oils, and concentrates. The company operates in 11 states, emphasizing growth through its hub strategy and a broad selection of THC and CBD products.
Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF) announced on January 21, 2022, that it filed a resale registration on Form S-1 with the SEC for Subordinate Voting Shares issued during 2021 acquisitions. A total of 1,577,600 shares were issued to stakeholders for acquisitions involving Patient Centric of Martha's Vineyard, Nature's Remedy, and others. The filing also included a post-effective amendment updating unaudited interim financials and details on Harvest Health & Recreation Inc. acquisitions. Trulieve won't sell any shares or receive proceeds from the registered sales.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
